Torrent or torment from the tubules?

Journal of the American College of Cardiology

Volumn 45, Issue 12, 2005, Pages 2004-2007

  Stevenson, Lynne Warner ^a,b,c   Nohria, Anju ^a   Mielniczuk, Lisa ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDTRONIC INC   (United States)

^c SCIOS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SODIUM; THIAZIDE DIURETIC AGENT;

CARDIORENAL SYNDROME; DISEASE COURSE; DIURESIS; FLUID RETENTION; HEART OUTPUT; HEART VOLUME; HYPONATREMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; NOTE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM RESTRICTION;

EID: 20444491269     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.03.028     Document Type: Editorial

References (21)

1. NHLBI Working Group. Cardio-Renal Connections in Heart Failure and Cardiovascular Disease. Available at: http://www.nhlbi.nih.gov/meetings/ workshops/cardiorenal-hf-hd.htm. Accessed April 30, 2005.
2. S. Paterna, P. Di Pasquale, G. Parrinello Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose of furosemide alone in refractory congestive heart failure a double-blind study J Am Coll Cardiol 45 2005 1997 2003
3. M.S. Weinfeld, G.M. Chertow, L. Warner Stevenson Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure Am Heart J 138 1999 285 290
4. S.S. Gottlieb, W. Abraham, J. Butler The prognostic importance of different definitions of worsening renal function in congestive heart failure J Card Fail 8 2002 136 141
5. D.E. Forman, J. Butler, Y. Wang Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
6. M. Volpe, C. Tritto, N. De Luca Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure J Clin Invest 88 1991 1481 1489
7. L. Warner Stevenson, J.H. Tillisch Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure Circulation 74 1986 1303 1308
8. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, L. Warner Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
9. P. Manunta, G. Bianchi Low-salt diet and diuretic effect on blood pressure and organ damage J Am Soc Nephrol 15 Suppl 1 2004 S43 S46
10. I.H. Zucker, A.J. Gorman, K.G. Cornish, M. Lang Impaired atrial receptor modulation or renal nerve activity in dogs with chronic volume overload Cardiovasc Res 19 1985 411 418
11. D.H. Ellison Diuretic resistance physiology and therapeutics Semin Nephrol 19 1999 581 597
12. D. Forman, J. Butler, Y. Wang Incidence, predictors, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
13. G. Licata, P. Di Pasquale, G. Parrinello Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure long-term effects Am Heart J 145 2003 459 466
14. M.H. Drazner, B.F. Palmer Hypertonic saline a novel therapy for advanced heart failure? Am Heart J 145 2003 377 379
15. S.S. Shankar, D.C. Brater Loop diuretics from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol 284 2003 F11 F21
16. W.H. Lee, M. Packer Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure Circulation 73 1986 257 267
17. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, C.W. Yancy, W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure classification and regression tree analysis JAMA 293 2005 572 580
18. A. Nohria, E. Lewis, L. Warner Stevenson Medical management of advanced heart failure JAMA 287 2002 628 640
19. M. Gheorghiade, I. Niazi, J. Ouyang Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure results from a double-blind, randomized trial Circulation 107 2003 2690 2696
20. S.S. Gottlieb, D.C. Brater, I. Thomas BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 2002 1348 1353
21. J. Butler, C. Emerman, W.F. Peacock, V.S. Mathur, J.B. Young The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure Nephrol Dial Transplant 19 2004 391 399